Examining factors associated with experiencing cardiac arrhythmias in Black and White breast cancer survivors who received anthracyclines or trastuzumab
Survivors with chronic conditions like hypertension and obesity may require enhanced cardiac surveillance. Further investigation into hypertension management in Black survivors may shed light on its impact on CV toxicities in this group.
Authors
- Vanessa B. Sheppard (ORCID: https://orcid.org/0000-0003-2874-6659)
- Katherine Y. Tossas (ORCID: https://orcid.org/0000-0001-6872-2294)
- Arnethea L. Sutton (ORCID: https://orcid.org/0000-0002-4398-0278)
- Wendy Bottinor (ORCID: https://orcid.org/0000-0002-6743-5776)
- Jian He (ORCID: https://orcid.org/0000-0003-3796-4623)
- Jinlei Zhao
Institutions
- Virginia Commonwealth University (US)
- Virginia Cancer Institute (US)
- VCU Massey Comprehensive Cancer Center (US)
Publication Details
- Journal
- Breast Cancer Research and Treatment
- Published
- 2025-03-27
- DOI
- https://doi.org/10.1007/s10549-025-07671-0
- Citations
- 2
- Primary Topic
- Chemotherapy-induced cardiotoxicity and mitigation
- Type
- article
- Field-Weighted Citation Impact
- 2.78
Funders
- National Institutes of Health
- National Cancer Institute